Filing Details

Accession Number:
0001593968-21-001992
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-18 19:43:27
Reporting Period:
2021-08-17
Accepted Time:
2021-08-18 19:43:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237564 M Steven Paul C/O Karuna Therapeutics, Inc.
99 High Street, 26Th Floor
Boston MA 02110
President &Amp; Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-17 1,183 $105.63 107,668 No 4 P Indirect See footnote (1)
Common Stock Acquisiton 2021-08-18 1,181 $106.10 108,849 No 4 P Indirect See footnote (1)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote (1)
No 4 P Indirect See footnote (1)
Footnotes
  1. The purchases reported on this Form 4 were effected by The Steven M. Paul Revocable Trust.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $105.62 to $105.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $105.95 to $106.13, inclusive.